REDMOND, WA, November 22, 2024 -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that the Company’s Chair and CEO Mark Anderson will be attending the Fortune Brainstorm AI 2024 conference December 9-10, 2024, at the St. Regis San [...]
REDMOND, Wash., Oct. 14, 2024-- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the Company has been invited to present at the BIO- Europe® 2024 conference. The 30th annual edition of BIO-Europe will take place from November 4-6, [...]
• Company meets all testing required to meet global EMC standards • Broadens ProSpectral™ multi-disease diagnostics research platform to serve diverse growth markets REDMOND, WA, September 24, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") is proud to [...]
Research collaboration leverages Pattern's ProSpectral™ multi-disease hyperspectral diagnostics research platform Potentially ushers in a new era of early detection cancer screening REDMOND, WA, August 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Pattern and [...]
REDMOND, WA, August 7, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the Company will be presenting at the LSX World Congress USA, which will be held in Boston, MA at the Hynes Convention Center. The [...]
Mark Anderson, Chair and CEO, joins renowned authors in contributing chapter entitled "The Future of AI: Pattern Discovery, Explainable AI, and Ethical AI"REDMOND, WA, August 6, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced the publication of [...]
Targets high-grade serous ovarian cancer, the most common and deadliest form of gynecologic cancer Underscores potential of Pattern Discovery Engine™ to uncover novel therapeutic combinations for hard-to-treat cancers REDMOND, WA, July 30, 2024 -- Pattern Computer®, Inc. ("Pattern" or [...]
New paper on sensing research collaboration with national labs available on medRxiv Hyperspectral sensing shown to enable agnostic reagent-free diagnostics Study addresses clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point [...]
Continued expansion of Pattern's IP portfolio Significant progress in expanding industry-leading oncology pipeline REDMOND, WA, June 12, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") announced at the Bio International Conference in San Diego that it is filing [...]
REDMOND, WA, May 22, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") proudly announces the initiation of synergy and efficacy testing for two promising drug combinations identified within its High-Grade Serous Ovarian Cancer (HGSOC) program. Armed with a [...]